NEW YORK (TheStreet) --aBrean CapitalaupgradedaNuVasivea ato "buy" from "hold" and set a $44 price target. The firm said theastockahas pulled back, even though fundamentals have improved. The stock closed at $35.02 on Monday. Must Read: Warren Buffett's 25 Favorite Stocks STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. Separately, TheStreet Ratings team rates NUVASIVE INC as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation: "We rate NUVASIVE INC (NUVA) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and growth in earnings per share. However, as a counter to these strengths, we find that the company's return on equity has been disappointing." You can view the full analysis from the report here: NUVA Ratings Report STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Click to view a price quote on NUVA. Click to research the Health Services industry.
from Latest TSC Headlines http://ift.tt/1vtV19Q
No comments:
Post a Comment